SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-K -
SEC Accession No. 0001213900-21-023861
Filing Date
2021-04-30
Accepted
2021-04-30 16:04:47
Documents
7
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-K  
1 primary_doc.xml 1-K 2790
2 ANNUAL REPORT PURSUANT TO REGULATION A ea139964-1k_emeraldhealth.htm PART II 645055
3 AMENDED AND RESTATED BYLAWS OF EMERALD HEALTH PHARMACEUTICALS INC ea139964ex2-3_emeraldhealth.htm EX1K-2B BYLAWS 150638
4 CONSENT OF DELOITTE & TOUCHE LLP ea139964ex11-1_emeraldhealth.htm EX1K-11 CONSENT 1477
5 GRAPHIC image_001.jpg GRAPHIC 53233
6 GRAPHIC image_002.jpg GRAPHIC 68119
7 GRAPHIC image_003.jpg GRAPHIC 21822
  Complete submission text file 0001213900-21-023861.txt   998669
Mailing Address 5910 PACIFIC CENTER BLVD SUITE 320, SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD SUITE 320, SAN DIEGO CA 92121 (858) 352-0622
Emerald Health Pharmaceuticals Inc. (Filer) CIK: 0001700800 (see all company filings)

IRS No.: 820669961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-K | Act: 33 | File No.: 24R-00152 | Film No.: 21877771
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences